Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

An international group of researchers led by Professor Colin Espie from the Nuffield Department of Clinical Neurosciences at the University of Oxford is investigating the impact of the COVID-19 pandemic on sleep and daily rhythms in adults.

An elderly man suffers from insomnia, trying to sleep. Backlight image in blue tones.

During the COVID-19 pandemic, difficulty getting to sleep, difficulty staying asleep and vivid dreaming have been widely reported across the general population. Some people may already have had sleep problems, and these seem to have got worse. Other people who were good sleepers before seem to have developed insomnia.

Sleep is at the heart of physical and mental health. It is essential for tissue repair, cell regeneration, immune functioning, memory functioning and consolation, and for the regulation of daytime emotion. When people are sleep deprived or develop a persistent sleep disorder, the consequences include loss of energy, sleepiness, impaired concentration and memory, and disturbed mood. Inadequate sleep has been associated with increased risk of hypertension and type 2 diabetes, and risk of developing anxiety or depression.

This study will look at changes in sleep quality in relation to social confinement such as a national lockdown or self-isolation, risk of exposure to the virus, and psychological symptoms such as anxiety, depression, and post-traumatic stress. Researchers aim to understand how sleep problems have emerged, and to investigate how sleep during COVID-19 has interacted with lifestyle, health and wellbeing.

Read more on the Nuffield Department of Clinical Neurosciences website

This story is also featured on the University of Oxford website

Similar stories

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations to Professor Gero Miesenböck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.

Major funding for Oxford will help find new cancer treatments

Cancer Research UK and the National Institute for Health and Care Research are investing over £3 million across the next five years into The University of Oxford’s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.

Daniel Freeman to join Department of Experimental Psychology as Professor of Psychology

The Department of Experimental Psychology are delighted to announce that Daniel Freeman has been appointed as their new Professor of Psychology, joining from the Department of Psychiatry.

New study reveals role of lymphatic system in bone healing

It was previously assumed that bones lacked lymphatic vessels, but new research from the MRC Human Immunology Unit at Oxford's MRC Weatherall Institute for Molecular Medicine not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.

Vaccination shown to protect against pregnancy complications from COVID-19 Omicron variant

The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries.